Lung & Thoracic Cancers

domain

Cancers of the lungs, pleura, and thoracic cavity, including NSCLC, SCLC, mesothelioma, and thymic tumors.

101

Centers

6,875

Active Trials

256

NIH Grants

$26.0B

NCI Funding

General Cancer Types(212)

NameCenters
Lung Non-Squamous Non-Small Cell Carcinoma84
Stage IV Lung Cancer AJCC v884
Lung Carcinoma83
Stage II Lung Non-Small Cell Cancer AJCC v781
Stage III Lung Cancer AJCC v878
Extensive Stage Lung Small Cell Carcinoma77
Lung Adenocarcinoma77
Stage II Lung Cancer AJCC v877
Lung Non-Small Cell Carcinoma74
Lung Non-Small Cell Squamous Carcinoma68
Lung Neuroendocrine Tumor66
Limited Stage Lung Small Cell Carcinoma65
Malignant Mesothelioma64
Advanced Lung Non-Small Cell Carcinoma57
Locally Advanced Lung Non-Small Cell Carcinoma53
Lung Small Cell Carcinoma52
Stage III Lung Non-Small Cell Cancer AJCC v741
Bladder Small Cell Neuroendocrine Carcinoma38
Lung Cancers38
Lung Neoplasm35
Stage III Lung Cancer AJCC v735
Advanced Lung Carcinoma33
Stage I Lung Cancer AJCC v732
Stage II Lung Cancer AJCC v732
Lung Squamous Cell Carcinoma31
Lung Large Cell Carcinoma28
Pleural Malignant Mesothelioma28
Epithelioid Mesothelioma27
Biphasic Mesothelioma18
Lung Neuroendocrine Neoplasm16
Refractory Lung Small Cell Carcinoma10
Lung Injury9
Interstitial Lung Disease8
Extrapulmonary Small Cell Neuroendocrine Carcinoma7
Malignant Lung Neoplasm7
Lung Cancer Survivors6
Lung Nodule6
Advanced Lung Small Cell Carcinoma5
Advance Lung Cancer4
Advanced Lung Adenocarcinoma4
Lung Cancer Prevention4
Acute Lung Injury3
Lung Biopsy3
Lungcancer3
Metastatic Lung Carcinoma3
Neuroendocrine Tumor of the Lung3
Non-Small Cell Lung Carcinoma (NSCLC)3
NSCLC Stage IV Without EGFR/ALK Mutation3
Small Cell Lung Cancer Recurrent3
Stage III Pleural Diffuse Malignant Mesothelioma AJCC v83
Stage III Unresectable Non-Small Cell Lung Cancer3
Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v83
Advanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)2
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)2
Advanced Malignancies, Non-small Cell Lung Cancer2
Advanced Malignant Mesothelioma2
Advanced Non Small Cell Lung Cancer (NSCLC)2
Advanced Nonsmall Cell Lung Cancer2
Advanced or Metastatic NSCLC2
Advanced Stage Non-small Cell Lung Cancer2
ALK-positive NSCLC2
ALK+ Advanced NSCLC2
Bronchoalveolar Cell Lung Cancer2
Cancer of Lung2
Chronic Lung Disease2
Early Stage Non-Small Cell Lung Cancer2
EGFR-mutated NSCLC (Disorder)2
Epithelial Mesothelioma2
Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer2
KRAS G12-mutant NSCLC2
Localized Malignant Mesothelioma2
Locally Advanced Non-small Cell Lung Cancer2
Lung Adenocarcinoma Metastatic2
Lung Adenocarcinoma Stage I2
Lung Cancer Stigma2
Lung Squamous Cell Carcinoma Stage IV2
Malignant Epithelial Mesothelioma2
Malignant Pleural Neoplasm2
Metastatic Non-Small Cell Lung Carcinoma2
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung2
Non-small Cell Lung Cancer Stage I2
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)2
NSCLC, Squamous or Non-Squamous2
NSCLC, Stage III2
NSCLC, Stage IIIC2
Refractory Non-Small Cell Lung Cancer2
RET-positive Non-small Cell Lung Cancer (NSCLC)2
Sarcomatous Mesothelioma2
Second Primary Lung Cancer2
Squamous Non Small Cell Lung Cancer (NSCLC-SCC)2
Thromboembolism of Vein in Non-small Cell Lung Cancer2
Adenocarcinoma of Lung, Stage IV1
Adenosquamous Cell Lung Cancer1
Advanced Non-Small Cell Lung Carcinoma1
Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer1
Advanced Thymic Epithelial Tumor1
Advanced/Metastatic NSCLC1
Biopsy Proven Non Small Cell Lung Cancer1
Blood Relatives of Patient w/Lung Cancer1
Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer1
EGFR Negative Non-Small Cell Lung Cancer1
EGFR-Mutant Lung Cancer1
EGFR-mutant Lung Cancers1
Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)1
KRAS Mutant Non-Small Cell Lung Cancer1
Locally Advanced Lung Carcinoma1
Locally Advanced NSCLC - Non-Small Cell Lung Cancer1
LUNG1
Lung Adenocarcinoma Stage II1
Lung Adenocarcinoma Stage III1
Lung Adenocarcinoma Stage IV1
Lung Cancer (Locally Advanced or Metastatic)1
Lung Cancer Non-Small Cell Cancer (NSCLC)1
Lung Cancer Squamous Cell1
Lung Cancer, Protection Against1
Lung Carcinoma Metastatic in the Brain1
Lung Metastases From Any Primary1
Lung Squamous Cell Carcinoma Stage I1
Malignant Epithelial Pleural Mesothelioma1
Malignant Mesothelioma (MPM)1
Malignant Pleural Disease1
Mesothelioma Malignant Advanced1
Metastatic Nonsmall Cell Lung Cancer1
Metastatic or Incurable Non-small Cell Lung Cancer1
Metastatic Squamous Non-Small Cell Lung Carcinoma1
Neuroendocrine Carcinoma of Lung1
Non Small Cell Lung Cancer Stage1
Non Small Lung Cancer1
Non-small Cell Lung Cancer - Enrollment Completed1
Non-small Cell Lung Cancer Stage II1
Non-small Cell Lung Cancer Stage ⅢA1
Non-Small Cell Lung Cancer Stage IIIA1
Non-Small Cell Lung Cancer, Head and Neck Cancer1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer1
Nonsmall Cell Lung Cancer Stage III1
Nonsmall Cell Lung Cancer, Stage II1
NSCLC Stage II1
NSCLC, Stage IIIA1
Oligometastatic Lung Adenocarcinoma1
Oligometastatic Non-small Cell Lung Cancer (NSCLC)1
Patients With Small Cell Lung Carcinoma and Other Neoplasms1
Pleural Carcinomatosis1
Pleural Malignancy1
Pleural Metastases1
Pleural Neoplasm1
Radiation Induced Lung Injury (RILI)1
Recurrent Extensive Stage Small Cell Lung Carcinoma1
Recurrent Lung Squamous Cell Carcinoma1
Recurrent Non-Small Lung Cell Cancer1
Refractory Extensive Stage Small Cell Lung Carcinoma1
Refractory Lung Adenocarcinoma1
Relapsed Malignant Mesothelioma1
RET-fusion Non Small Cell Lung Cancer1
Single or Multiple Lung Metastases1
Single Primary Lung Cancer1
Small Cell Carcinoma of the Lung1
Smokers at Risk of Lung Cancer1
Squamous Lung Dysplasia1
Stage I Non-Small Cell Lung Cancer AJCC v71
Stage IA Malignant Mesothelioma1
Stage IA Non-Small Cell Lung Carcinoma AJCC v71
Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v81
Stage IB Malignant Mesothelioma1
Stage II Malignant Mesothelioma1
Stage III Malignant Mesothelioma1
Stage IIIA Lung Carcinoma1
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER1
Stage IIIb Lung Cancer1
Stage IIIB Lung Carcinoma1
Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v81
Stage IV Lung Squamous Cell Carcinoma AJCC v71
Stage IV Malignant Mesothelioma1
Thymic Carcinoid1
Thymic Malignancies1
Thymic Neuroendocrine Tumors1
Transformed Small Cell Lung Cancer1
Unresectable Mesothelioma1
Unresectable Non-Small Cell Lung Carcinoma1
Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)1
Untreated Stage IV or Recurrent Squamous Cell Lung Cancers1
Advanced Lung Neuroendocrine Neoplasm
Combined Lung Carcinoma
Diffuse Malignant Mesothelioma
Digestive System Small Cell Neuroendocrine Carcinoma
Lung Adenocarcinoma by AJCC v7 Stage
Lung Cancer by AJCC v6 Stage
Lung Cancer by AJCC v7 Stage
Lung Cancer by AJCC v8 Stage
Lung Cancer Pathologic Regional Lymph Nodes TNM Finding v6
Lung Cancer Pathologic TNM Finding v7
Lung Disorder
Lung Large Cell Carcinoma by AJCC v7 Stage
Lung Neuroendocrine Carcinoma
Lung Non-Small Cell Cancer by AJCC v7 Stage
Lung Sarcoma
Lung Small Cell Carcinoma Molecular Subtypes
Lung Squamous Cell Carcinoma by AJCC v7 Stage
Metastatic Carcinoma in the Lung
Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma
Metastatic Small Cell Sarcoma
Peritoneal Malignant Mesothelioma
Pleural Diffuse Malignant Mesothelioma by AJCC v7 Stage
Pleural Diffuse Malignant Mesothelioma by AJCC v8 Stage
Stage I Lung Cancer AJCC v9
Stage I Lung Non-Small Cell Cancer AJCC v7
Stage I Lung Small Cell Carcinoma AJCC v7
Stage I Pleural Diffuse Malignant Mesothelioma AJCC v7
Stage I Pleural Diffuse Malignant Mesothelioma AJCC v8
Stage II Lung Cancer AJCC v9
Stage II Lung Small Cell Carcinoma AJCC v7
Stage III Lung Cancer AJCC v9
Stage IV Lung Cancer AJCC v9

Top Centers for Lung & Thoracic Cancers(101)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
2
3
4
NCI Comprehensive
5
NCI Comprehensive
6
7
NCI Comprehensive
8
NCI Comprehensive
9
10
Cedars-Sinai CancerLos Angeles, CA
11
NCI Comprehensive
12
NCI Clinical
13
14
NCI Comprehensive
15
NCI Comprehensive
16
17
18
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
19
20
NCI Basic_laboratory
21
22
23
24
25
NCI Comprehensive
26
27
NCI Comprehensive
28
NCI Comprehensive
29
30
31
NCI Comprehensive
32
NCI Comprehensive
33
NCI Comprehensive
34
NCI Comprehensive
35
NCI Comprehensive
36
NCI Comprehensive
37
NCI Comprehensive
38
39
NCI Comprehensive
40
NCI Comprehensive
41
NCI Comprehensive
42
43
44
NCI Comprehensive
45
NCI Comprehensive
46
47
48
49
50
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
51
52
NCI Comprehensive
53
NCI Comprehensive
54
55
NCI Comprehensive
56
NCI Comprehensive
57
58
NCI Comprehensive
59
NCI Clinical
60
NCI Comprehensive
61
NCI Comprehensive
62
NCI Comprehensive
63
64
NCI Clinical
65
NCI Comprehensive
66
67
68
NCI Comprehensive
69
NCI Comprehensive
70
71
72
73
74
75
76
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
77
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
78
79
NCI Basic_laboratory
80
NCI Basic_laboratory
81
82
NCI Comprehensive
83
84
85
86
87
88
89
90
91
92
93
94
WVU Cancer InstituteMorgantown, WV
95
96
97
98
99
100
BC CancerVancouver, BC
101

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →